Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
945 Leser
Artikel bewerten:
(2)

Zepp Health: ZEPP HEALTH RANKED TOP FIVE IN GLOBAL SMARTWATCH SHIPMENTS IN 2021

Finanznachrichten News

Global sales continued to excel in Brazil, Turkey, Italy, and the Czech Republic in Q4 2021

CUPERTINO, Calif., March 18, 2022 /PRNewswire/ -- Zepp Health (NYSE: ZEPP), a global smart wearable and health technology leader, completed the final quarter of 2021 with yet another season of sharp and steady growth, and achieved a top-five ranking in global adult watch shipments, according to new data from the International Data Corporation's (IDC) Worldwide Quarterly Wearable Device Tracker.

ZEPP HEALTH RANKED TOP FIVE IN GLOBAL SMARTWATCH SHIPMENTS IN 2021

Throughout 2021, Zepp Health's leading brands, Amazfit and Zepp, achieved a faster shipment growth rate than the global overall growth rate, with more than 6.81 million adult watches shipped worldwide.

The company's global performance was consistently impressive in the final quarter of 2021, maintaining first place in Brazil and achieving first place in Turkey, while continuing to be ranked second in Italy, Spain, the Czech Republic and Indonesia.

"We are seeing tremendous growth from companies like Zepp Health, who are gaining market share because its connected watch brands like Amazfit and Zepp offer consumers a wide variety of watches giving them options to pick the best one to suit their health, fitness, and lifestyle needs", said Jitesh Ubrani, Research Manager, Worldwide Mobile Device Trackers, IDC.

Commenting on this achievement, Zepp Health CEO Wayne Huang said: "Our ranking demonstrates Zepp Health's commitment to leveraging the power of technology to empower people to live their healthiest lives. We are grateful for this recognition as we continue to focus on delivering customized and connected smart wearables solutions built around human-centric innovation."

Focusing on encouraging users to live their passions and express their active spirits freely, Zepp Health's award-winning brand Amazfit offers several series of connected watches designed for daily and outdoor sports use. Among the Top 50 models on the market outside of the Chinese mainland, 11 were of the Amazfit brand, including the flagship Amazfit GTR 3 and GTS 3 Series and the high-level outdoor Amazfit T-Rex Pro.

The Zepp premium smartwatch brand is dedicated to crafting professional and stylish designs, which utilize advanced data analysis technologies to offer a comprehensive, in-depth and precise understanding of users' health metrics.

The Zepp Health Digital Health Management Platform, along with its Zepp OS, Zepp App and Zepp Life app powers million users worldwide.

About Zepp Health

Zepp Health, a global smart wearable and health technology leader, empowers users to live their healthiest lives by optimizing their fitness and wellness journeys through its leading consumer brands, Amazfit and Zepp.

Powered by its proprietary Zepp Health Digital Health Management Platform, which includes the Zepp OS, AI Chips, biometric sensors, and data algorithms, Zepp Health delivers cloud-based 24/7 actionable insights and guidance to help users attain their wellness goals.

The company has also applied its AI expertise to emerging industrial medical imaging technologies and delivers big data and analytics capabilities to support medical and diagnostic service providers.

To date, Zepp Health has shipped over 200 million units and its products are available in 90+ countries. Founded in 2013 as Huami Corp., the company became Zepp Health in February 2021. Zepp Health has 1,300 team members, with offices across the North America, EMEA and APAC regions. For more information, visit www.zepphealth.com

Photo - https://mma.prnewswire.com/media/1769041/image.jpg

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.